zhejiang shenghua biok bio-a
(600226:Shanghai Stock Exchange)
zhejiang shenghua biok bio-a (600226) Snapshot
|
Open
--
|
Previous Close
--
|
|
|
Day High
--
|
Day Low
--
|
|
|
52 Week High
-- - --
|
52 Week Low
-- - --
|
|
|
Market Cap
--
|
Average Volume 10 Days
0.0
|
|
|
EPS TTM
--
|
Shares Outstanding
0.0
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
zhejiang shenghua biok bio-a (600226) Related Businessweek News
No Related Businessweek News Foundzhejiang shenghua biok bio-a (600226) Details
Zhejiang Shenghua Biok Biology Co.,Ltd. engages in the manufacture and export of bio-agrochemicals and medicaments for animal nutrition and health in China. It offers feed additives, which comprise colistin sulphate, flavomycin, monensin, salinomycin sodium, maduramicin ammonium, diclazuril, tiamulin hydrogen fumarate, tilmicosin, ivermenctin, tiamulin fumarate premixes, colistin suplphate premixes, salinomycin premixes, maduramcin ammonium premixes, diclazuril premixes, pleuromutilin, and avermectin premixes/powder. The company also provides crop protection products, such as abamectin, dicamba, dichloro salicylic acid, emamectin benzoate, gibberellins, 6-benzylamino purine, beta-cypermecthrin avermectin, phoxim.avermectin, triazophos.avermectin, and gibb-purine; and amino acids and pharma products, including L-tryptophan, L-phenylalanine, and L-glutathione reduced. Zhejiang Shenghua Biok Biology Co.,Ltd. was founded in 1993 and is based in Deqing, China.
zhejiang shenghua biok bio-a (600226) Key Developments
Zhejiang Shenghua Biok Biology Co., Ltd., Board Meeting, Apr 24, 2013. Agenda: To discuss and approve the proposal of the first quarter report of 2013; and to consider the proposal of appointing Deputy General Manager.
Zhejiang Shenghua Biok Biology Co., Ltd. announced that they will report Q1, 2013 results on Apr 25, 2013
Zhejiang Shenghua Biok Biology Co., Ltd., Board Meeting, Apr 01, 2013. Agenda: To discuss and approve the scheme of profit distribution of 2012, the annual report of 2012 and its abstract; and to discuss and approve the proposal of daily connected transactions of 2012 and prediction on daily connected transaction of 2013.
| Recently Viewed | |||
| 600226:CH | CNY5.75 CNY | -0.09 | |
| Company | Last | Change | |
| No competitor information is available for 600226. | |||
| View Industry Companies | |||
Industry Analysis
600226
Industry Average
| Valuation | 600226 | Industry Range |
| Price/Earnings | 67.3x |
|
| Price/Sales | 1.5x |
|
| Price/Book | 1.8x |
|
| Price/Cash Flow | 64.3x |
|
| TEV/Sales | 1.1x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact ZHEJIANG SHENGHUA BIOK BIO-A, please visit www.biok.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.







